辉瑞中国
- 网络pfizer china
辉瑞中国
-
全国政协委员,辉瑞中国企业事务部总监冯丹龙
Feng Danlong , CPPCC National Committee member and Pfizer China corporate affairs director
-
跨国经营海外子公司业务发展中企业的战略选择&辉瑞制药中国公司在华生产范围发展路径(1993~2002年)的启示
Strategic Choices for Firms in Expanding Overseas Business
-
辉瑞公司在中国成立了一个“俱乐部”,该俱乐部以开会的名义邀请那些“开药量较大”的医生参加各种娱乐活动。
In China Pfizer established a " club " that provided " high-prescribing " doctors with all kinds of entertainment under the guise of attending conferences .
-
在辉瑞以680亿美元收购惠氏(Wyeth)后,去年9月,中国商务部命令辉瑞剥离在中国内地的猪流感疫苗业务,以换取合并交易在当地获得通过。
In exchange for local merger clearance , China 's commerce ministry last September instructed Pfizer to divest its swine flu vaccine on the mainland following its $ 68bn takeover of Wyeth .